Testing effectiveness (Phase 2)Study completedNCT05091346
What this trial is testing
E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid Tumors
Who this might be right for
MelanomaCarcinoma, HepatocellularColorectal Neoplasms
Eisai Inc. 89